Optimizing clinical use of azathioprine with newer pharmacogenetic data

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)707-710
Number of pages4
JournalArchives of Dermatology
Volume145
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Drug Dose Response Relationship
Drug Administration Schedule
Vesiculobullous Skin Diseases
Maximum Tolerated Dose
Pharmacogenetics
Azathioprine
Atopic Dermatitis
Immunosuppressive Agents
Vasculitis
Sensitivity and Specificity

ASJC Scopus subject areas

  • Dermatology

Cite this

Optimizing clinical use of azathioprine with newer pharmacogenetic data. / Wolverton, Stephen.

In: Archives of Dermatology, Vol. 145, No. 6, 06.2009, p. 707-710.

Research output: Contribution to journalArticle

@article{3bc1bf7697164c7b97354bbd70818d15,
title = "Optimizing clinical use of azathioprine with newer pharmacogenetic data",
author = "Stephen Wolverton",
year = "2009",
month = "6",
doi = "10.1001/archdermatol.2009.95",
language = "English",
volume = "145",
pages = "707--710",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Optimizing clinical use of azathioprine with newer pharmacogenetic data

AU - Wolverton, Stephen

PY - 2009/6

Y1 - 2009/6

UR - http://www.scopus.com/inward/record.url?scp=67449156120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449156120&partnerID=8YFLogxK

U2 - 10.1001/archdermatol.2009.95

DO - 10.1001/archdermatol.2009.95

M3 - Article

VL - 145

SP - 707

EP - 710

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 6

ER -